FIELD: biotechnology.
SUBSTANCE: antibody specifically linking with claudin 18A2 is proposed. Immunoconjugates including the said antibody, a chimeric antigenic receptor to detect claudin 18A2, an immune cell modified with a chimeric antigenic receptor that are used for preparation of antitumoral medical remedies and reagents for diagnostics of tumors expressing claudin 18A2 are also proposed. Moreover, nucleic acids for production of antibodies, immunoconjugates and chimeric antigenic receptors are disclosed.
EFFECT: increased cytotoxic activity in relation to cells expressing claudin 18A2.
35 cl, 27 dwg, 7 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY TO IL-13RA2 AND ITS APPLICATION | 2018 |
|
RU2756623C2 |
| CHIMERIC ANTIGEN RECEPTORS TO MYELOMA KAPPA ANTIGEN AND VERSIONS OF THEIR APPLICATION | 2016 |
|
RU2743188C2 |
| ANTIBODY TO CLDN18.2 AND ITS USE | 2018 |
|
RU2797709C2 |
| HUMAN NECTIN-2 SPECIFIC ANTIBODIES | 2020 |
|
RU2820275C2 |
| GD2 BINDING MOLECULE | 2020 |
|
RU2824670C2 |
| TUMOR-SPECIFIC ANTI-EGFR ANTIBODY AND USE THEREOF | 2016 |
|
RU2730605C2 |
| CHIMERIC ANTIGENIC RECEPTORS TO CD22 | 2012 |
|
RU2644243C2 |
| CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS | 2020 |
|
RU2824672C2 |
| ANTIBODIES SPECIFIC TO HUMAN NECTIN-4 | 2019 |
|
RU2825839C2 |
| ANTIBODY AGAINST CLAUDIN 18A2 AND ITS USE | 2020 |
|
RU2811431C2 |
